Approximately 7,000 of Canada’s roughly 75,000 physicians are prescribing cannabis to patients. Of these, approximately 3,161 or 45% of prescribing physicians report recommending CanniMed Therapeutics Inc. products.
The Company commissioned an independent third-party study in July 2014 to examine attitudes and behaviours related to medical cannabis among Canadian physicians. The survey measured physician prescribing habits, current views, concerns, knowledgeability, interest and attitudes towards governing bodies and available clinical information. A second study was commissioned by the Company in October 2016 with identical questions to the 2014 survey. The differences in prescribing details between the 2014 and 2016 Physician survey results suggest a shift in attitudes and prescribing practices among Canadian physicians:
- Number of physicians currently prescribing up 9% over a two year period; number of physicians ‘who will not prescribe medical cannabis under any circumstances’ down 9% over the same period.
- Physicians that are interested in prescribing but have not done so yet, or require more information before prescribing remain the same at 52%.
- 32% of physicians feel they are properly informed on medical cannabis, similar result from 2014.
- Physicians are increasingly being approached by patients about prescribing medical cannabis with 78% indicating having been approached in the last 6 months, versus 48% in the 2014 survey.
- Chronic pain and neuropathic pain were cited by prescribing physicians as the most common condition for which medical cannabis would be prescribed by them (2016 results).